DD284020A5 - Neues verfahren zum optischen auftrennen von racemischen spiro-hydantoinen - Google Patents

Neues verfahren zum optischen auftrennen von racemischen spiro-hydantoinen Download PDF

Info

Publication number
DD284020A5
DD284020A5 DD89331128A DD33112889A DD284020A5 DD 284020 A5 DD284020 A5 DD 284020A5 DD 89331128 A DD89331128 A DD 89331128A DD 33112889 A DD33112889 A DD 33112889A DD 284020 A5 DD284020 A5 DD 284020A5
Authority
DD
German Democratic Republic
Prior art keywords
racemic
compound
dione
hydantoin
spiro
Prior art date
Application number
DD89331128A
Other languages
German (de)
English (en)
Inventor
Marcus Bracksen
Harry R Howard Jr
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD284020A5 publication Critical patent/DD284020A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DD89331128A 1988-07-27 1989-07-25 Neues verfahren zum optischen auftrennen von racemischen spiro-hydantoinen DD284020A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/224,966 US4952694A (en) 1988-07-27 1988-07-27 Novel resolution process for racemic spiro-hydantoins

Publications (1)

Publication Number Publication Date
DD284020A5 true DD284020A5 (de) 1990-10-31

Family

ID=22842974

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89331128A DD284020A5 (de) 1988-07-27 1989-07-25 Neues verfahren zum optischen auftrennen von racemischen spiro-hydantoinen

Country Status (24)

Country Link
US (1) US4952694A (ru)
EP (1) EP0352959B1 (ru)
JP (1) JPH0625152B2 (ru)
KR (1) KR910002839B1 (ru)
CN (1) CN1023645C (ru)
AT (1) ATE93859T1 (ru)
DD (1) DD284020A5 (ru)
DE (1) DE68908812T2 (ru)
DK (1) DK169033B1 (ru)
EG (1) EG18934A (ru)
ES (1) ES2058537T3 (ru)
FI (1) FI893576A (ru)
HU (1) HU204527B (ru)
IE (1) IE892420L (ru)
IL (1) IL91055A0 (ru)
MX (1) MX173143B (ru)
MY (1) MY104136A (ru)
NO (1) NO168773C (ru)
NZ (1) NZ230091A (ru)
PL (1) PL161181B1 (ru)
PT (1) PT91273A (ru)
RU (1) RU1777599C (ru)
YU (1) YU47209B (ru)
ZA (1) ZA895680B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151544A (en) * 1990-05-25 1992-09-29 Alcon Laboratories, Inc. Intermediates in the preparation of chiral spirofluorenehydantoins
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
US5811605A (en) * 1997-02-19 1998-09-22 Ppg Industries, Inc. Preparation of 1,2,3,3-tetrachloropropene
WO2009011261A1 (ja) 2007-07-19 2009-01-22 Tokuyama Corporation ヒダントイン環を有する化合物及びその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
DE3367103D1 (en) * 1982-11-10 1986-11-27 Pfizer Sorbinil by optical resolution with aminopinane derivatives
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
WO1986002647A1 (en) * 1984-10-30 1986-05-09 Pfizer Inc. Spiro-heteroazolones for treatment of diabetes complications

Also Published As

Publication number Publication date
JPH0625152B2 (ja) 1994-04-06
DK367889A (da) 1990-01-29
NO168773B (no) 1991-12-23
NO893053D0 (no) 1989-07-26
ATE93859T1 (de) 1993-09-15
YU47209B (sh) 1995-01-31
US4952694A (en) 1990-08-28
ZA895680B (en) 1991-03-27
PT91273A (pt) 1990-02-08
FI893576A0 (fi) 1989-07-26
NO168773C (no) 1992-04-01
FI893576A (fi) 1990-01-28
MY104136A (en) 1994-02-28
KR910002862A (ko) 1991-02-26
AU3898889A (en) 1990-02-01
JPH0288576A (ja) 1990-03-28
PL161181B1 (pl) 1993-05-31
DE68908812T2 (de) 1993-12-09
KR910002839B1 (ko) 1991-05-06
MX173143B (es) 1994-02-02
EP0352959A1 (en) 1990-01-31
EG18934A (en) 1994-03-30
CN1023645C (zh) 1994-02-02
AU603301B2 (en) 1990-11-08
YU149189A (en) 1991-02-28
EP0352959B1 (en) 1993-09-01
HU204527B (en) 1992-01-28
NO893053L (no) 1990-01-29
NZ230091A (en) 1991-01-29
ES2058537T3 (es) 1994-11-01
HUT56369A (en) 1991-08-28
CN1040199A (zh) 1990-03-07
IL91055A0 (en) 1990-02-09
DE68908812D1 (de) 1993-10-07
DK169033B1 (da) 1994-08-01
MX16955A (es) 1993-06-01
RU1777599C (ru) 1992-11-23
DK367889D0 (da) 1989-07-26
IE892420L (en) 1990-01-27

Similar Documents

Publication Publication Date Title
DE69909611T2 (de) Reagenz zum nachweis von singulett-sauerstoff
DE68908812T2 (de) Verfahren zur Spaltung racemischer Spirohydantoine.
AT401650B (de) Verfahren zur herstellung eines zwischenproduktes von diltiazem
EP0414020B1 (de) Verfahren zur Herstellung von Clausenamid und Neoclausenamid und deren Derivate
DE69308222T2 (de) Katalysator zur asymmetrischen Induktion
DE69623117T2 (de) Verfahren zur herstellung von 4-hydroxy-2-pyrrolidon
DE69107546T2 (de) Verfahren zur Herstellung von Insektiziden, Akariziden und Nematiziden-2-Aryl-5-(trifluormethyl)-Pyrrolen.
EP0600460A1 (de) Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsäure
DE2720088C2 (ru)
DD240207A5 (de) Verfahren zur herstellung asymmetrischer hydantoine
EP0243734B1 (de) Optisch aktive Hydantoine
US5006657A (en) Intermediates in a resolution process for racemic spiro hydantoins
EP0115811B1 (de) 2,4-Dichlor-5-thiazolcarboxaldehyd und ein Verfahren zu seiner Herstellung
DE69008431T2 (de) Verfahren zur Herstellung von Imidazol-Derivaten.
DD209443A5 (de) Verfahren zur herstellung von acylaminoderivaten von 1-(aryl- oder subst.-aryl)amino-1-thioalkancarboxysaeuren
DE3590057C1 (de) Verfahren zur Herstellung von Diacyldianhydrohexiten
DE4340408A1 (de) Derivate von Tricyclochinazolin und Verfahren zu ihrer Herstellung
AT366673B (de) Verfahren zur herstellung neuer phthalazin-4ylessigs[uren und deren salze
DE10019291A1 (de) 2-Alkoxy-5-methoxypyrimidine bzw. deren tautomere Formen sowie Verfahren zu ihrer Herstellung
EP0347678A2 (de) 1,4-Dihydropyridin-threonin-Derivate und Verfahren zu ihrer Herstellung
DD273381A5 (de) Verfahren zur herstellung einer spiro-azolonverbindung
EP0030916B1 (de) Azatetracyclische Carbonitrile
DE4032054A1 (de) Verfahren zur herstellung von optisch aktiven 4-aryl-2-pyrrolidinonen
EP1299394A1 (de) Verfahren zur herstellung von (+)-biotin
DE3826603A1 (de) Verfahren zur stereoselektiven synthese von 5-(chinoxalin-2'-yl)-imidazolidin-2,4-dionen sowie neue zwischenprodukte

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee